FMR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.993700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.442000E-01
Normal-vs-Stage2
9.188500E-02
Normal-vs-Stage3
5.516200E-02
Normal-vs-Stage4
4.209200E-01
Stage1-vs-Stage2
9.723200E-01
Stage1-vs-Stage3
1.236160E-01
Stage1-vs-Stage4
5.620400E-01
Stage2-vs-Stage3
1.648390E-01
Stage2-vs-Stage4
5.744200E-01
Stage3-vs-Stage4
1.135580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.513700E-02
Normal-vs-AfricanAmerican
2.676000E-01
Normal-vs-Asian
2.432600E-01
Caucasian-vs-AfricanAmerican
4.565800E-01
Caucasian-vs-Asian
8.036600E-01
AfricanAmerican-vs-Asian
6.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.920000E-02
Normal-vs-Female
5.240400E-02
Male-vs-Female
7.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.685600E-01
Normal-vs-Age(41-60Yrs)
2.601800E-01
Normal-vs-Age(61-80Yrs)
4.081900E-02
Normal-vs-Age(81-100Yrs)
9.342800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.306400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.729400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.659180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.661700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.061600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.575400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.127800E-02
Normal-vs-Daily Drinker
5.606000E-02
Normal-vs-Weekly Drinker
5.849600E-02
Normal-vs-Occasional Drinker
2.252200E-01
Normal-vs-Social Drinker
1.646240E-01
Non Drinker-vs-Daily Drinker
5.416800E-01
Non Drinker-vs-Weekly Drinker
7.038600E-01
Non Drinker-vs-Occasional Drinker
4.267800E-01
Non Drinker-vs-Social Drinker
7.227400E-01
Daily Drinker-vs-Weekly Drinker
8.699400E-01
Daily Drinker-vs-Occasional Drinker
2.117600E-01
Daily Drinker-vs-Social Drinker
4.064800E-01
Weekly Drinker-vs-Occasional Drinker
3.117600E-01
Weekly Drinker-vs-Social Drinker
5.220800E-01
Occasional Drinker-vs-Social Drinker
7.254600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.430760E-01
Normal-vs-Grade 2
3.075800E-02
Normal-vs-Grade 3
2.528200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.953700E-02
Grade 1-vs-Grade 3
4.462000E-02
Grade 1-vs-Grade 4
1.430760E-01
Grade 2-vs-Grade 3
4.311000E-01
Grade 2-vs-Grade 4
3.075800E-02
Grade 3-vs-Grade 4
2.528200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.511880E-02
Normal-vs-NonDiabetic
7.962000E-02
Diabetic-vs-NonDiabetic
8.459700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.715170E-01
Normal-vs-NoPancreatitis
5.563900E-02
Pancreatitis-vs-NoPancreatitis
6.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.833600E-02
Normal-vs-N1
8.927800E-02
N0-vs-N1
5.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.536800E-01
Normal-vs-TP53-NonMutant
1.520200E-01
TP53-Mutant-vs-TP53-NonMutant
2.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
